BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1110 related articles for article (PubMed ID: 6263995)

  • 1. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
    Kanda K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the follow up period of postmolar patient (author's transl)].
    Hando T; Maruyama S; Watanabe S; Hirogami T; Obata N; Kanazawa K; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar; 34(3):287-91. PubMed ID: 7069243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the probable prevention of postmolar choriocarcinoma (author's transl)].
    Arai S
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):89-95. PubMed ID: 7061897
    [No Abstract]   [Full Text] [Related]  

  • 4. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biochemical properties of urinary human chorionic gonadotropin from the patients with trophoblastic disease.
    Nishimura R; Endo Y; Tanabe K; Ashitaka Y; Tojo S
    J Endocrinol Invest; 1981; 4(3):349-58. PubMed ID: 7320438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological and biochemical properties of human chorionic gonadotropin from urine of patients with hydatidiform mole and its radioimmunoassay (author's transl)].
    Nishimura R; Hamamoto T; Tanabe K; Takemori M; Ashitaka Y; Tojo S
    Nihon Naibunpi Gakkai Zasshi; 1981 Nov; 57(11):1632-44. PubMed ID: 7327293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of the gonadotrophin response to LH-RH and oestrogen administration in patients after molar abortion.
    Miyake A; Aono T; Tanizawa O; Kurachi H; Kurachi K
    Acta Endocrinol (Copenh); 1979 May; 91(1):30-5. PubMed ID: 222100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the results of hydatidiform mole managed by Niigata method].
    Hando T; Kodama S; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2722-30. PubMed ID: 4086902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The excretion of chorionic gonadetropin in 55 cases of hydatidiform mole (author's transl)].
    Lichtenegger W; Weiss PA
    Geburtshilfe Frauenheilkd; 1977 Apr; 37(4):334-7. PubMed ID: 192629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of choriocarcinoma by the hCG beta-to-hCG proportion in patients with delayed diagnosis caused by contraceptive use.
    Vartiainen J; Alfthan H; Lehtovirta P; Stenman UH
    Contraception; 1998 Apr; 57(4):257-60. PubMed ID: 9649918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of remission in trophoblastic disease as seen from serum hCG level (author's transl)].
    Hirashima N
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):592-600. PubMed ID: 6263999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria of complete remission from trophoblastic neoplasia with the use of human chorionic gonadotropin (HCG) excretion pattern as a parameter.
    Tomoda Y; Asai Y; Arii Y; Kaseki S; Nishi H; Miwa T; Saiki N; Ishizuka N
    Cancer; 1977 Sep; 40(3):1016-25. PubMed ID: 198083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients.
    Hajri T; Massoud M; Vergne M; Descargues P; Allias F; You B; Lotz JP; Haesebaert J; Bolze PA; Golfier F; Massardier J
    Am J Obstet Gynecol; 2024 Mar; 230(3):362.e1-362.e8. PubMed ID: 37722570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on follow-up procedure for postmolar patients].
    Endo N; Kobayashi O; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):531-8. PubMed ID: 6715935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of chorionic gonadotropin detection in urine samples in the diagnosis of hydatid mole (serologic technic)].
    Wawryk J
    Ginekol Pol; 1976 Sep; 47(9):1011-5. PubMed ID: 992460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative immunologic assay of human chorionic gonadotropin in normal and abnormal pregnancies.
    Mishell DR; Davajan V
    Am J Obstet Gynecol; 1966 Sep; 96(2):231-9. PubMed ID: 5921063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
    Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
    Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological criteria for the surveillance of hydatidiform moles and choriocarcinomas].
    Roger M; Feinstein-Soldat MC; Emmanuel J; Scholler R
    J Gynecol Obstet Biol Reprod (Paris); 1977 Mar; 6(2):207-25. PubMed ID: 886170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.